BioCentury | Mar 28, 2011
Company News

Matrixx Initiatives pharmaceuticals news

...disclosing all kinds of adverse event reports, but this is basically a status quo decision." Matrixx Initiatives Inc....
BioCentury | Feb 14, 2011
Company News

Matrixx Initiatives deal

...of $44.8 million and a net loss of $8.4 million (see BioCentury, Dec. 20, 2010). Matrixx Initiatives Inc....
BioCentury | Jan 17, 2011
Politics, Policy & Law

Materially insignificant

...about adverse events. How much more will depend on where the justices draw the line. Matrixx Initiatives Inc....
...and Institutions Mentioned BayBio , South San Francisco, Calif. Biotechnology Industry Organization (BIO), Washington, D.C. Matrixx Initiatives Inc....
BioCentury | Dec 20, 2010
Company News

Matrixx Initiatives Inc. deal

...$67.3 million and a net loss of $23.6 million. Sawaya Segalas & Co. advised Matrixx. Matrixx Initiatives Inc....
BioCentury | Nov 16, 2010
Top Story

U.S. backs more AE disclosures

...Matrixx Inc., et al. v. Siracusano, et al. , a class action suit alleging that Matrixx Initiatives Inc....
BioCentury | Oct 4, 2010
Company News

Scolr Pharma board of directors update

...Bothell, Wash. Business: Drug delivery Appointed: Carl Johnson as chairman, formerly president and CEO of Matrixx Initiatives Inc....
BioCentury | May 22, 2006
Finance

NASDAQ additions

...$11.29 -10% Genomic Health (GHDX) $10.55 2% GTx (GTXI) $8.53 0% Inhibitex (INHX) $1.90 -5% Matrixx Initiatives...
Items per page:
1 - 7 of 7
BioCentury | Mar 28, 2011
Company News

Matrixx Initiatives pharmaceuticals news

...disclosing all kinds of adverse event reports, but this is basically a status quo decision." Matrixx Initiatives Inc....
BioCentury | Feb 14, 2011
Company News

Matrixx Initiatives deal

...of $44.8 million and a net loss of $8.4 million (see BioCentury, Dec. 20, 2010). Matrixx Initiatives Inc....
BioCentury | Jan 17, 2011
Politics, Policy & Law

Materially insignificant

...about adverse events. How much more will depend on where the justices draw the line. Matrixx Initiatives Inc....
...and Institutions Mentioned BayBio , South San Francisco, Calif. Biotechnology Industry Organization (BIO), Washington, D.C. Matrixx Initiatives Inc....
BioCentury | Dec 20, 2010
Company News

Matrixx Initiatives Inc. deal

...$67.3 million and a net loss of $23.6 million. Sawaya Segalas & Co. advised Matrixx. Matrixx Initiatives Inc....
BioCentury | Nov 16, 2010
Top Story

U.S. backs more AE disclosures

...Matrixx Inc., et al. v. Siracusano, et al. , a class action suit alleging that Matrixx Initiatives Inc....
BioCentury | Oct 4, 2010
Company News

Scolr Pharma board of directors update

...Bothell, Wash. Business: Drug delivery Appointed: Carl Johnson as chairman, formerly president and CEO of Matrixx Initiatives Inc....
BioCentury | May 22, 2006
Finance

NASDAQ additions

...$11.29 -10% Genomic Health (GHDX) $10.55 2% GTx (GTXI) $8.53 0% Inhibitex (INHX) $1.90 -5% Matrixx Initiatives...
Items per page:
1 - 7 of 7